Histiocytosis Syndromes

Histiocytosis Syndromes: Overview - Cell Chaos Crew

• Group of rare disorders: characterized by ↑ proliferation & accumulation of histiocytes (macrophages or dendritic cells).
• Classification based on cell lineage:
  • Langerhans Cell Histiocytosis (LCH): CD1a+, S100+, Langerin (CD207)+. Most common.
  • Non-Langerhans Cell Histiocytoses (Non-LCH): e.g., Juvenile Xanthogranuloma (JXG), Rosai-Dorfman disease.
  • Malignant Histiocytoses.

⭐ Birbeck granules (tennis-racket appearance on Electron Microscopy) are pathognomonic for Langerhans Cell Histiocytosis (LCH).

Histiocytosis Syndromes: LCH - Bone's Bizarre Battle

• Langerhans Cell Histiocytosis (LCH): Clonal proliferation of Langerhans cells, characterized by Birbeck granules (tennis-racket appearance on Electron Microscopy).
• Immunophenotype: CD1a+, S100+, Langerin (CD207)+.
• Commonly associated with BRAF V600E mutation (~50%).
• Clinical Forms:
  • Unifocal (Eosinophilic Granuloma): Solitary, lytic bone lesion (skull, femur); may affect skin, lung. Best prognosis.
  • Multifocal Unisystem (Hand-Schüller-Christian Disease): Classic triad: lytic bone lesions (skull), diabetes insipidus, exophthalmos. (📌 HAnd: Skull lesions, DI, Exophthalmos).
  • Multifocal Multisystem (Letterer-Siwe Disease): Aggressive; infants < 2 years. Features: skin rash (seborrheic-like), hepatosplenomegaly, lymphadenopathy, fever, cytopenias. Poorest prognosis.
• Treatment: Varies by extent; observation, curettage, steroids, chemotherapy (e.g., vinblastine, prednisone).

⭐ Birbeck granules, appearing as tennis-racket shaped intracytoplasmic organelles on electron microscopy, are pathognomonic for Langerhans Cell Histiocytosis (LCH).

Histiocytosis Syndromes: HLH - Cytokine Storm Troopers

HLH: Life-threatening hyperinflammation. Uncontrolled lymphocyte/macrophage activation → cytokine storm (↑IFN-γ, TNF-α). Due to impaired NK/CD8+ T cell function.

• Types:
  • Primary (Familial): Genetic (e.g., PRF1, UNC13D, STX11)
  • Secondary: Infections (EBV, CMV), malignancy (lymphoma), autoimmune (SLE, JIA).
• Diagnosis (HLH-2004, ≥5/8 criteria):
  • Fever ≥38.5°C
  • Splenomegaly
  • Cytopenias (≥2 lines): Hb <9 g/dL, Platelets <100x10⁹/L, Neutrophils <1.0x10⁹/L
  • Hypertriglyceridemia (fasting, ≥3 mmol/L) OR Hypofibrinogenemia (≤1.5 g/L)
  • Hemophagocytosis (bone marrow/spleen/lymph nodes)
  • ↓/absent NK cell activity
  • Ferritin ≥500 µg/L
  • Soluble CD25 (sIL-2R) ≥2400 U/mL
• Treatment: Suppress inflammation (steroids, etoposide, cyclosporine A), treat underlying cause. Hematopoietic Stem Cell Transplant (HSCT) for familial/refractory cases.

⭐ Markedly elevated ferritin (often >10,000 µg/L) is a highly characteristic, though not solely diagnostic, finding in HLH supporting rapid investigation and intervention.

Histiocytosis Syndromes: Non-LCH Rarities - Rare Cell Rebels

• Juvenile Xanthogranuloma (JXG)
  • Benign; commonest non-LCH.
  • Skin: Yellow-brown papules/nodules.
  • Micro: Touton giant cells.
  • Usually spontaneous regression.
• Rosai-Dorfman Disease (RDD) (Sinus Histiocytosis with Massive Lymphadenopathy)
  • Painless, massive cervical lymphadenopathy.
  • Micro: Emperipolesis (lymphocytes within histiocytes).
  • Markers: S100+, CD68+, CD1a-.
• Erdheim-Chester Disease (ECD)
  • Rare, multi-systemic; older adults.
  • Symmetric osteosclerosis of long bones (painful).
  • BRAF V600E mutation common.

⭐ Rosai-Dorfman Disease is characterized by emperipolesis - the presence of intact lymphocytes within the cytoplasm of S100-positive histiocytes an important diagnostic feature for MCQs.

High‑Yield Points - ⚡ Biggest Takeaways

• LCH: Characterized by Birbeck granules (tennis-racket) on EM; CD1a & S100 positive.
• Most common LCH site: bone (skull); presents with lytic lesions.
• Hand-Schüller-Christian triad: lytic bone lesions, diabetes insipidus, exophthalmos.
• BRAF V600E mutation is common in LCH.
• HLH: Life-threatening cytokine storm; features include fever, splenomegaly, cytopenias.
• Key HLH diagnostic markers: ↑ ferritin, ↑ sCD25, ↓ NK cell activity, hypertriglyceridemia.
• HLH can be primary (genetic) or secondary (e.g., infections, malignancy).